With advances in technology coupled with falling costs, the bottleneck in drug discovery has shifted from data generation to data analysis. Today, biological data is produced at a pace much faster than that of gathering insights from the same.
We believe that the latest advances in tech and data science can eliminate the bottlenecks around processing, analyzing and visualizing large and complex datasets. This will enable scientists and doctors in biotech, pharma, and hospitals to make effective, real-time decisions.
We aim to improve the odds of translating phenotypic screenings to therapeutic strategies by accelerating the process of drug discovery. Our platforms are build to integrate end-to-end workflows, from processing raw data to visualization, and empower collaborative and reproducible research.